Archives

by in
Entry Author Date Location
ZymoGenetics CEO Doug Williams Exits the Stage, Mulls Next Free Agent Move 11/08/10 Seattle
ZymoGenetics Melanoma Drug Shows Survival Data, Adding More Juice to Bristol’s Pipeline 09/29/10 Seattle
Biotech Drug Discovery in Seattle: A Look Back 06/11/10 Seattle
VentiRx Nabs $25M, Gilead Deepens Seattle Roots, Sage Strikes Deal With Pfizer & More Seattle-Area Life Sciences News 01/14/10 Seattle
Alder Rises from Ashes, Seattle Genetics Gets Empowered, ZymoGenetics Nets $79M & More Seattle-Area Life Sciences News 01/07/10 Seattle
ZymoGenetics On the Prowl to Raise $85M in Stock Deal 01/06/10 Seattle
Cell Therapeutics Dangles Exec Bonuses, Oncothyreon’s Turnaround Year, VLST Layoffs, & More Seattle-Area Life Sciences News 12/24/09 Seattle
ZymoGenetics Regains Full U.S. Rights to Recothrom as Bayer Walks Away 12/21/09 Seattle
Zymo Application Yanked in EU 12/14/09 Seattle
ZymoGenetics Axes 52 Jobs, Quits Discovery of Immunology Drugs, to Conserve Cash 12/03/09 Seattle
ZymoGenetics, King Pharma Brawl Over Drugs to Control Surgical Bleeding 11/09/09 Seattle
ZymoGenetics’ Former Medical Boss Leads Rival Startup, ProFibrix, With Drug For Bleeding 10/26/09 Seattle
ZymoGenetics Plays Hardball, Targeted Genetics’ Legacy, Omeros Preps for Fall IPO, & More Seattle-Area Life Sciences News 08/27/09 Seattle
ZymoGenetics, Citing Two Patient Deaths, Builds Up Ammunition for Case Against Rival 08/20/09 Seattle
ZymoGenetics Plays Hardball, Asks FDA to Pull Competing Drug Off Market Because of Safety 08/20/09 Seattle
AVI Bolts to Seattle, OncoGenex Escapes Dendreon’s Shadow, Buddhists Helping Biotech, & More Seattle-Area Life Sciences News 08/06/09 Seattle
Zymo Gets $6M in Q2 Recothrom Sales 08/03/09 Seattle
ZymoGenetics Drug Sales Still Slumping After Full Year on Market 05/05/09 Seattle
ZymoGenetics Cuts One-Third of Workforce To Hold Onto Cash 04/29/09 Seattle
ZymoGenetics Sales Chief Exits 02/04/09 Seattle
ZymoGenetics’ New Boss Sees Parallels to Dark Days at Immunex 01/05/09 Seattle
Blood News: A Quick Rundown of Headlines From the American Society of Hematology 12/09/08 National
ZymoGenetics Drug For Surgical Bleeding Demonstrates Safety in Trial 12/08/08 Seattle
ZymoGenetics Cash Gets Lean, Recothrom Sales Still Slow 11/04/08 Seattle
ZymoGenetics’ Kidney Cancer Drug, Taken with Nexavar, Shrinks Tumors in Relapsed Patients 10/22/08 Seattle
Seattle Genetics’ Medical Point Man, Tom Reynolds, Aims to Capitalize on Hodgkin’s Drug 09/08/08 Seattle
ZymoGenetics, Bayer Drug Vying for European Regulatory Approval 09/02/08 Seattle
ZymoGenetics Sells Land for $11.5 Million 08/29/08 Seattle
ZymoGenetics Drug Getting Off to Slow Start in Marketplace 08/06/08 Seattle
ZymoGenetics Receives $100 Million Commitment From Deerfield 06/30/08 Seattle
Page 1 of 1